Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Health Study (LHS) I and III
NCT00000568Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1984
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ipratropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1984; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00000568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000568.